Status
Conditions
Treatments
About
The main aim of this study is to determine and compare the optimal time to achieve peak concentration of blood plasma nitrite after ingestion of beetroot juice (BR) and isotonic beetroot juice (ISO-CB), respectively. Optimal timing of drink consumption in relation to exercise can then be prescribed in relation to nitrite appearance in the blood. A randomised controlled trial with participants completing two conditions: (i) BR and (ii) ISO-CB. On each condition participants will consume During each trial, participants will ingest 2 x 285ml of beverage 3 hours prior to performing two jump tests follow by a Wingate test. Salivary NO content will be measured at the start of the morning, 1 hour, 2 hours, 3 hours after consumption of beverage and at the end of the exercise.
Full description
A randomised controlled trial recruiting 24 healthy male and female participants. Each participant will complete two conditions: (i) BR and (ii) ISO-CB. On each condition participants will consume During each trial, participants will ingest 2 x 285ml of beverage 3 hours prior to performing two jump tests follow by a Wingate test. In the next trial, participants will undergo the same procedures, but ingest the beverage that they did not take the previous round. The study will be double-blinded study. Blood samples will be taken before supplementation, 2 hours and 3 hours after consuming the beverage. Salivary NO content will be measured at the start of the morning, 1 hour, 2 hours, 3 hours after consumption of beverage and at the end of the exercise. For each trial, participants will also fill out a sensory evaluation form in relation to the drink consumed. It is hypothesized that blood plasma nitrite and saliva nitrite appearance will be earlier with ISO-CB and that participants will have improved peak and mean power when ISO-CB is consumed compared with BR.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
28 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal